Coffee intake before brain imaging may influence results, study says
Heavy coffee consumption results in lower dopamine activity in the striatum, a brain region affected in Parkinson’s disease, and…
Articles by Patricia Inácio, PhD
G2019S mutation carriers in LRRK2 gene have higher Parkinson’s risk
People who carry the G2019S mutation in the LRRK2 gene, the most common one associated with Parkinson’s disease, have a 10…
Identifying AAK1 inhibitor could aid therapy discovery: Study
Scientists have harnessed the power of a protein-screening technology to identify a novel inhibitor of AAK1, an enzyme linked with…
Parkinson’s mitochondria-targeting research nets $12.5M more funding
Lucy Therapeutics‘ (LucyTx) overall funding haul has grown to $36 million with the addition of $12.5 million more to…
Cell therapy bemdaneprocel gets FDA RMAT status
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to bemdaneprocel, a cell therapy…
Genetic ancestry’s contribution to Parkinson’s, brain disorders shown
A first-of-its kind study has identified key genes in the brain that explain why Black Americans have a lower incidence…
Phase 1 trial in Sweden to test IRL757 for neurological apathy
Irlab Therapeutics is preparing to start a Phase 1 clinical trial of IRL757, its oral tablet candidate to ease…
Test of alpha-synuclein protein may help in Parkinson’s diagnosis: Study
A test known as the alpha-synuclein seed amplification assay, or alphaSyn-SAA, was able to measure the accumulation of alpha-synuclein protein…
Neuroprotective effect seen in cannabinol and its analogs
Researchers have developed analogs of cannabinol (CBN), a lesser-known cannabinoid, that show neuroprotective abilities in lab studies not…
Machine learning approaches can benefit Parkinson’s research: Study
Scientists exploring the potential of machine learning approaches in drug discovery for Parkinson’s disease and other neurodegenerative disorders —…